Assessment of the clinical usefulness of nebulised ipratropium bromide in patients with chronic airflow limitation.
- 1 April 1984
- Vol. 39 (4), 272-276
- https://doi.org/10.1136/thx.39.4.272
Abstract
The effect of adding nebulised ipratropium bromide to bronchodilator treatment was studied in 20 patients with severe chronic airflow limitation. Maintenance theophylline with or without a steroid preparation was continued and comparison made between placebo, nebulised salbutamol, and a combination of nebulised salbutamol and ipratropium. Although the mean FEV1 values showed the combination to produce a small but significant increase in peak bronchodilatation over the effect of salbutamol alone, there were eight patients in whom no clinically useful improvement occurred. The remaining 12 patients did obtain clinically useful improvement in the magnitude or the duration of bronchodilatation (or both) as a result of the added ipratropium. The conclusion is that individual patients with chronic airflow limitation responded to the addition of nebulised ipratropium bromide in a variable way. Patients who could obtain additional benefit from ipratropium need to be identified by an appropriate reversibility study before its inclusion in their bronchodilator treatment.Keywords
This publication has 13 references indexed in Scilit:
- Ipratropium BromideDrugs, 1980
- Combined Cholinergic Antagonist and β2-Adrenoceptor Agonist Bronchodilator Therapy by InhalationAustralian and New Zealand Journal of Medicine, 1979
- Bronchodilatation and the site of airway resistance in severe chronic bronchitis.Thorax, 1979
- Comparison of ipratropium bromide and fenoterol in asthma and chronic bronchitis.British Journal of Clinical Pharmacology, 1978
- The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis.Thorax, 1978
- Aerosol Therapy with Sch 1000Chest, 1978
- Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitisRespiratory Medicine, 1978
- Bronchodilator Action of the Anticholinergic Drug, Ipratropium Bromide (Sch 1000), as an Aerosol in Chronic Bronchitis and AsthmaChest, 1977
- A comparison of the bronchodilator activity of Sch 1000 and salbutamolJournal of Allergy and Clinical Immunology, 1977
- Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma.BMJ, 1975